(NASDAQ: MDLN) Medline's forecast annual revenue growth rate of 8.7% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.6%.
Medline's revenue in 2026 is $28,432,000,000.On average, 29 Wall Street analysts forecast MDLN's revenue for 2026 to be $41,414,184,813,300, with the lowest MDLN revenue forecast at $39,521,152,606,608, and the highest MDLN revenue forecast at $42,926,245,930,512. On average, 29 Wall Street analysts forecast MDLN's revenue for 2027 to be $44,598,577,643,988, with the lowest MDLN revenue forecast at $42,406,023,339,360, and the highest MDLN revenue forecast at $46,749,093,759,432.
In 2028, MDLN is forecast to generate $48,032,572,222,956 in revenue, with the lowest revenue forecast at $45,699,452,723,244 and the highest revenue forecast at $50,959,481,144,892.